| name | Example Drug A |
| classification | Anti-inflammatory |
| pharmacokinetics | Rapid absorption after intramuscular injection, peak plasma levels within 1-2 hours. Primarily metabolized in the liver, with elimination half-life of 4-6 hours. |
| suggested dosage | | adult | | initial dose | 250 mg IM | | maintenance dose | 250 mg IM every 6-8 hours as needed for pain | | maximum daily dose | 1.5 grams |
|
|
| indications | | 1 | Pain related to acute muscle sprains and strains | | 2 | Post-surgical pain | | 3 | Fever reduction |
|
| safety in pregnancy | Limited data available. Potential risk of fetal harm exists. Consult with physician before use during pregnancy. |
| safety in breastfeeding | Potentially passes into breast milk. Consult with physician before use during breastfeeding. |
| side effects | | 1 | Nausea | | 2 | Vomiting | | 3 | Diarrhea | | 4 | Headache | | 5 | Dizziness | | 6 | Skin rash | | 7 | Allergic reactions (rare) | | 8 | Gastrointestinal bleeding (rare) |
|
| alternatives | |
| contraindications | | 1 | Known hypersensitivity to the drug or any of its components | | 2 | Active gastrointestinal bleeding | | 3 | Severe renal impairment | | 4 | History of ulcerative colitis or Crohn's disease |
|
| interactions | | 1 | Aspirin and other NSAIDs may increase the risk of bleeding | | 2 | Warfarin and other anticoagulants may increase the risk of bleeding | | 3 | Alcohol may increase the risk of gastrointestinal upset |
|
| warnings and precautions | | 1 | Monitor for signs of gastrointestinal bleeding, such as black stools or vomiting blood | | 2 | Patients with renal impairment may require dose adjustments | | 3 | Avoid concurrent use with other NSAIDs without physician consultation | | 4 | Use with caution in patients with a history of heart problems | | 5 | Do not administer intravenously |
|
| additional information | For IM injection, use sterile technique. Inject deep into the muscle, avoiding large blood vessels. Do not use if the solution appears cloudy or discolored. Store medication as prescribed. |
| dosing instructions | | 1 | | method | Intramuscular (IM) | | site | | 1 | Deltoid muscle | | 2 | Gluteal muscle |
| | angle | 90 degrees | | depth | 1 to 1.5 inches |
| | 2 | | method | Dosage adjustments may be necessary for patients with renal impairment or other significant health conditions. | | details | Consult a healthcare professional for specific dosage guidelines. |
|
|
